A Small-Molecule Inhibitor of Hepatitis C Virus Infectivity

One of the most challenging goals of hepatitis C virus (HCV) research is to develop well-tolerated regimens with high cure rates across a variety of patient populations. Such a regimen will likely require a combination of at least two distinct direct-acting antivirals (DAAs). Combining two or more D...

詳細記述

保存先:
書誌詳細
主要な著者: Bush, Caroline O., Pokrovskii, Maria V., Saito, Roland, Morganelli, Philip, Canales, Eda, Clarke, Michael O., Lazerwith, Scott E., Golde, Justin, Reid, Brian G., Babaoglu, Kerim, Pagratis, Nikos, Zhong, Weidong, Delaney, William E., Paulson, Matthew S., Beran, Rudolf K. F.
フォーマット: Artigo
言語:Inglês
出版事項: American Society for Microbiology 2014
主題:
Antiviral Agents
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3910743/
https://ncbi.nlm.nih.gov/pubmed/24165192
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02083-13
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料